Stocks and Investing Stocks and Investing
Wed, October 13, 2021

David Macdonald Maintained (AMED) at Strong Buy with Decreased Target to $190 on, Oct 13th, 2021


Published on 2024-10-27 18:08:46 - WOPRAI, David Macdonald
  Print publication without navigation


David Macdonald of Truist Securities, Maintained "Amedisys, Inc." (AMED) at Strong Buy with Decreased Target from $255 to $190 on, Oct 13th, 2021.

David has made no other calls on AMED in the last 4 months.



There are 9 other peers that have a rating on AMED. Out of the 9 peers that are also analyzing AMED, 4 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Whit Mayo of "SVB Leerink" Initiated at Hold and Held Target at $170 on, Monday, September 27th, 2021
  • Gary Taylor of "Cowen & Co." Initiated at Hold and Held Target at $195 on, Friday, September 10th, 2021
  • Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $237 on, Friday, August 6th, 2021
  • Joanna Gajuk of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $220 on, Thursday, August 5th, 2021


These are the ratings of the 5 analyists that currently disagree with David


  • Andrew Mok of "UBS" Initiated at Strong Sell and Held Target at $150 on, Friday, September 24th, 2021
  • A.J. Rice of "Credit Suisse" Maintained at Buy with Decreased Target to $250 on, Wednesday, August 11th, 2021
  • John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $250 on, Tuesday, August 10th, 2021
  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $235 on, Tuesday, August 10th, 2021
  • Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $265 on, Friday, August 6th, 2021

Contributing Sources